Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jordan Js VerPlank

3PUBLICATIONS
4CO-AUTHORS
Proteins and peptidesPeripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Oct 14, 2024
Pharmacologically increasing cGMP improves proteostasis and reduces neuropathy in mouse models of CMT1.

Seth M Moore, Joseph Gawron, Mckayla Stevens

|Feb 06, 2024
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy.

Jordan Js VerPlank, Joseph M Gawron, Nicholas J Silvestri

|Jun 10, 2020
cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases.

Jordan J S VerPlank, Sylwia D Tyrkalska, Angeleen Fleming

Pageof 1

Frequent Collaborators

1 joint publications

Sylwia D Tyrkalska

1 joint publications

Angeleen Fleming

1 joint publications

David C Rubinsztein

1 joint publications

Alfred L Goldberg

Frequent Collaborators

1 joint publications

Sylwia D Tyrkalska

1 joint publications

Angeleen Fleming

1 joint publications

David C Rubinsztein

1 joint publications

Alfred L Goldberg

Top Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on : May 02, 2025

107
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on : Jan 07, 2014

7.6K
Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on : Aug 28, 2016

12.4K
See more related videos

Top Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on : May 02, 2025

107
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on : Jan 07, 2014

7.6K
Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on : Aug 28, 2016

12.4K
See more related videos